Magnesium Hydroxide is NOT Appropriate for Treating Hypercalcemia
Magnesium hydroxide should be avoided in hypercalcemia management—it is a laxative with no role in lowering calcium levels and may theoretically worsen the condition by increasing intestinal calcium absorption.
Why Magnesium Hydroxide is Contraindicated
The 2023 Endocrine Society guidelines for hypercalcemia of malignancy make no mention of magnesium hydroxide as a treatment option 1. This omission is deliberate—magnesium compounds have no calcium-lowering properties and are fundamentally inappropriate for this indication.
Key Problems with Magnesium Hydroxide in Hypercalcemia:
No mechanism to lower calcium: Magnesium hydroxide is an antacid and osmotic laxative 2. It does not inhibit bone resorption, enhance renal calcium excretion, or reduce intestinal calcium absorption—the three pillars of hypercalcemia treatment 3
May increase intestinal calcium absorption: As an alkalinizing agent, magnesium hydroxide could theoretically enhance calcium absorption from the gut, potentially worsening hypercalcemia
Causes diarrhea with electrolyte losses: Excessive use leads to severe diarrhea 4, which can cause dehydration and paradoxically worsen hypercalcemia by reducing renal calcium clearance
Risk of hypermagnesemia: In patients with renal impairment (common in hypercalcemia), magnesium hydroxide can cause dangerous hypermagnesemia 4
Evidence-Based Treatment for Hypercalcemia
The correct first-line treatments are 1:
- IV bisphosphonates or denosumab (strong recommendation for all hypercalcemia of malignancy)
- Add calcitonin for severe cases (calcium >14 mg/dL or 3.5 mmol/L) for rapid effect in first 48-72 hours 1
- Aggressive IV hydration to restore normovolemia and enhance renal calcium excretion 3
Treatment Algorithm:
- Mild-moderate hypercalcemia: IV bisphosphonate (zoledronic acid preferred) or denosumab + IV saline
- Severe hypercalcemia (>14 mg/dL): Calcitonin + IV bisphosphonate/denosumab + aggressive IV hydration 1
- Refractory cases: Switch to denosumab if on bisphosphonate 1
Critical Pitfall to Avoid
Do not confuse magnesium supplementation (which has no effect on calcium levels in hypoparathyroid patients 5) with hypercalcemia treatment. Magnesium hydroxide is indicated only for constipation and acid reflux 2—never for calcium disorders.
The only role for reducing intestinal calcium absorption in hypercalcemia involves dietary calcium restriction and potentially glucocorticoids for specific etiologies (granulomatous disease, lymphoma)—not magnesium compounds 3.